---
title: "Industrial hemp concept stocks opened strong, with Rhine Biotech hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252581011.md"
description: "Rhein Biotech hit the daily limit, Fuan Pharmaceutical and CCGB rose over 5%, while Yongji Co., Ltd., Dezhan Health, Chengzhi, and Kang En Bei also followed suit"
datetime: "2025-08-12T01:32:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252581011.md)
  - [en](https://longbridge.com/en/news/252581011.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252581011.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/252581011.md) | [繁體中文](https://longbridge.com/zh-HK/news/252581011.md)


# Industrial hemp concept stocks opened strong, with Rhine Biotech hitting the daily limit

Rhein Biotech hits the daily limit, Fuan Pharmaceutical and CCGB rise over 5%, Yongji Co., Ltd., Dezhan Health, Chengzhi, and Kang En Bei also follow suit

### Related Stocks

- [Chengzhi (000990.CN)](https://longbridge.com/en/quote/000990.CN.md)
- [Fuan Pharmaceutical (300194.CN)](https://longbridge.com/en/quote/300194.CN.md)
- [CCGB (300138.CN)](https://longbridge.com/en/quote/300138.CN.md)

## Related News & Research

- [Glenmark Pharmaceuticals to Launch Potassium Phosphates Injection in March](https://longbridge.com/en/news/279206533.md)
- [BYD mulls new plant in Canada – and the acquisition of a global carmaker](https://longbridge.com/en/news/279256751.md)
- [BYD weighs Canada plant, legacy automaker buyout amid global push](https://longbridge.com/en/news/278974771.md)
- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/279032574.md)
- [Rajasthan to begin mustard, gram procurement at MSP from March 25](https://longbridge.com/en/news/279268681.md)